Alexander Hardy

Alexander Hardy

Chief Executive Officer at BIOMARIN PHARMACEUTICAL INC.

Net worth: 3 M $ as of 30/06/2026

57 year
Health Technology
Consumer Services

Profile

Alexander Hardy is currently President, Chief Executive Officer & Director at BioMarin Pharmaceutical, Inc. since 2023.
Mr. Hardy is also a Director at Pharmaceutical Research & Manufacturers of America and a Member of The Wall Street Journal CEO Council.
Formerly, Mr. Hardy was Chief Executive Officer & Director at Genentech, Inc. Mr. Hardy completed undergraduate studies at the University of Cambridge and earned an MBA from the Stephen M.
Ross School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
07/04/2026 52,422 ( 0.03% ) 3 M $ 30/06/2026

Alexander Hardy active positions

CompaniesPositionStart
BIOMARIN PHARMACEUTICAL INC. Chief Executive Officer 01/12/2023
The Wall Street Journal CEO Council
Corporate Officer/Principal -
Director/Board Member -

Former positions of Alexander Hardy

CompaniesPositionEnd
Chief Executive Officer -
See the detail of Alexander Hardy's experience

Training of Alexander Hardy

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

68

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

The Wall Street Journal CEO Council

  1. Stock Market
  2. Insiders
  3. Alexander Hardy